SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.68-2.4%Dec 12 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (4212)6/28/2001 3:08:51 PM
From: aknahow   of 52153
 
Fits with the cash is trash theory. If you have tons of cash and can't immediately use it for research or acquisitions you have to get rid of it in the present low interest rate phase. Buying ones shares makes more sense than accepting a meager return on the investment of these funds. Should a deal come along the shares can be reissued. Am aware that in the biotech area many have done and will make share offerings. The fact that many sheep have done it makes it easier to convince the remaining sheep to follow along. XOMA could not resist the guys in expensive suits either. <g>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News